UAE’s First Case with Vivolight Multimodal P80 OCT System

Dubai, United Arab Emirates — June 2, 2026

Vivolight Multimodal P80 OCT system has successfully completed its first clinical case at Aster Hospital Mankhool in UAE, marking an important milestone for advanced intravascular imaging in PCI guidance.

Located in Dubai, Aster Hospital Mankhool is a leading multispecialty hospital known for its comprehensive clinical services and patient-centered care. The hospital was ranked #4 in the UAE in Newsweek’s World’s Best Hospitals 2026 ranking, reflecting its continued commitment to clinical excellence and high-quality healthcare delivery.

The successful completion of this first case demonstrates the growing adoption of OCT-guided PCI in the Middle East and highlights the value of high-resolution intravascular imaging in supporting more precise coronary intervention.

A Milestone for OCT-Guided PCI in the UAE

As the first Vivolight Multimodal P80 OCT system installed in the UAE, this case represents a significant step forward in bringing AI-based advanced intravascular imaging into routine interventional cardiology practice.

The procedure was performed by Dr. Nawid and involved a complex three-vessel coronary artery disease case. In one of the most distal lesions, the lumen area was measured at only approximately 1.0 mm², presenting a significant challenge for intravascular imaging catheter delivery. Thanks to the excellent crossability of the Vivolight OCT catheter, the system successfully passed through the distal narrowed segment and enabled precise lesion assessment.

OCT imaging indicated features consistent with a fibrous plaque, providing important information to support treatment strategy selection, including the use of a drug-coated balloon. By offering AI-based streamline pre-PCI assessment of the lesion, the Vivolight P80 system helped the clinical team make more informed procedural decisions.

Post-PCI OCT Assessment and Stent Optimization

Following stent implantation, the Vivolight P80 system was used for post-PCI OCT assessment. The platform provided high-resolution cross-sectional and longitudinal views of the treated vessel segment, together with automated quantitative analysis of lumen dimensions, stent apposition, and stent expansion.

In the post-procedural OCT review, the system-reviewed segment showed 100% stent apposition, while the stent expansion analysis displayed a mean stent expansion of 85% and a minimum stent area of 5.01 mm². These quantitative OCT insights supported the clinical team in evaluating the immediate stent result and demonstrated the practical value of imaging-guided PCI for procedural optimization.

Advancing Precision Cardiovascular Care

The first successful clinical use of the UAE’s first Vivolight P80 OCT system at Aster Hospital Mankhool lays a strong foundation for broader adoption of OCT-guided PCI in the country.

Beyond high-resolution intravascular imaging, the Vivolight P80 is designed as a multimodal OCT platform that integrates three key technologies into one workflow: OCT-derived FFR for functional assessment of coronary stenosis, Index of Plaque Attenuation (IPA) for plaque stability assessmentand Intelligent Calcium Assessment (ICA) for automated calcium evaluation. These multimodal insights can be obtained from a single OCT pullback, helping physicians assess physiological significance,vessel morphology, plaque characteristics,  and calcium severity within the same imaging platform.

For PCI procedures, this integrated workflow can support lesion assessment, treatment strategy selection, lesion preparation, stent sizing, and treatment optimization. In this first UAE case, the system demonstrated not only clear imaging performance and reliable catheter delivery in a challenging distal lesion, but also practical value in supporting precise, image-guided decision-making.

The successful completion of this case also marks another important step in Vivolight’s expansion into high-end international cardiovascular imaging markets. Vivolight will continue working with clinical partners across the Middle East to expand access to advanced intravascular imaging solutions and support more precise, efficient, and patient-centered cardiovascular care.